| 1 |
Ernest-Suarez K, Panaccione R. Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis. Therap Adv Gastroenterol 2023;16:17562848231158235. [PMID: 36923487 DOI: 10.1177/17562848231158235] [Reference Citation Analysis]
|
| 2 |
Ferreiro-iglesias R, Piqueras M, Ricart E, Sempere L, Roca M, Martín de Carpi J, Bentitez O, Zabana Y, Mañosa M, Rodríguez-moranta F, Barreiro-de Acosta M. Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel Disease patients. Gastroenterología y Hepatología (English Edition) 2022. [DOI: 10.1016/j.gastre.2022.03.004] [Reference Citation Analysis]
|
| 3 |
Mangipudi UK, Jena A, Sharma V. Multi-dermatomal Herpes Zoster in a young patient with Crohn's disease on thiopurine therapy: Need for reconsidering vaccine recommendations. Dig Liver Dis 2022;54:1279-80. [PMID: 35491390 DOI: 10.1016/j.dld.2022.03.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Khan N, Wang L, Trivedi C, Pernes T, Patel M, Xie D, Yang Y. Efficacy of Recombinant Zoster Vaccine in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 2022;20:1570-1578.e1. [DOI: 10.1016/j.cgh.2021.07.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 5 |
Steenholdt C, Kristensen LE, Brynskov J. Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to Tofacitinib. Am J Gastroenterol 2022;117:195-6. [PMID: 34983891 DOI: 10.14309/ajg.0000000000001510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Napolitano M, D'Amico F, Ragaini E, Peyrin-Biroulet L, Danese S. Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy. Drug Des Devel Ther 2022;16:1897-913. [PMID: 35747444 DOI: 10.2147/DDDT.S340459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 7 |
Macaluso FS, Liguori G, Galli M. Vaccinations in patients with inflammatory bowel disease. Dig Liver Dis 2021;53:1539-45. [PMID: 34116972 DOI: 10.1016/j.dld.2021.05.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 8 |
D'Amico F, Magro F, Peyrin-Biroulet L, Danese S. Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis. J Crohns Colitis 2022;16:835-44. [PMID: 34791103 DOI: 10.1093/ecco-jcc/jjab206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 9 |
Robertson-More C, Wu T. A knowledge gap unmasked: viral transmission in surgical smoke: a systematic review. Surg Endosc 2021;35:2428-39. [PMID: 33495880 DOI: 10.1007/s00464-020-08261-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Hirota K. Air contamination with SARS-CoV-2 in the operating room. J Anesth 2021;35:333-6. [PMID: 32562137 DOI: 10.1007/s00540-020-02814-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
